Related Experiment Video
Updated: Sep 5, 2025

11:29
miRNA Expression Analyses in Prostate Cancer Clinical Tissues
Published on: September 8, 2015
10.9K
MTA1: A Vital Modulator in Prostate Cancer
Jialu Ma1, Chunxiao Li2, Haili Qian2
1Graduate School of Hebei Medical University, Shijiazhuang, China.
Current Protein & Peptide Science
|July 6, 2022
Summary
Metastasis-associated antigen-1 (MTA1) is crucial in prostate cancer (PCa) progression and bone metastasis. Targeting MTA1 presents a promising new therapeutic strategy for PCa prevention and treatment.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Prostate cancer (PCa) is a leading cause of cancer-related death in men globally, with rising incidence in Asia.
- Metastasis-associated antigen-1 (MTA1), a transcriptional coregulator, plays a key role in cell signaling and epithelial cell progression.
- MTA1 expression is specifically associated with PCa bone metastases, indicating its significance in disease advancement.
Approach:
- This review synthesizes current research on MTA1's structure, function, and expression in prostate cancer.
- It examines the role of MTA1 in PCa development, progression, and metastasis.
- The review also explores therapeutic strategies targeting MTA1 for PCa treatment.
Key Points:
- MTA1 is implicated in the formation, progression, and metastasis of prostate cancer.
- MTA1's involvement in histone deacetylation and nucleosome remodeling impacts cancer cell behavior.
- Specific links between MTA1 expression and PCa bone metastases highlight its clinical relevance.
Conclusions:
- MTA1 is a critical factor in prostate cancer pathogenesis and metastasis.
- Targeting MTA1 offers a potential novel therapeutic avenue for managing prostate cancer.
- Further research into MTA1-targeted drugs could lead to improved PCa treatment outcomes.
Related Concept Videos
mTOR Signaling and Cancer Progression
3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.9K
PI3K/mTOR/AKT Signaling Pathway
3.9K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.9K
Mitogens and the Cell Cycle
6.6K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.6K
Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
Microtubule Associated Proteins (MAPs)
4.5K
Microtubule function and architecture are regulated by an array of specialized proteins called microtubule-associated proteins or MAPs. These proteins are widespread across different organisms and have conserved protein motifs, like the multi-TOG domain for tubulin binding found in the CLASP family of MAPs. Some MAPs are lineage-specific based on their conserved domains. Their functions depend upon the cytoskeletal architecture and cell type they are located within. In-plant cells, a specific...
4.5K
Drugs that Stabilize Microtubules
2.1K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.1K

